Embla Medical hf.: Embla Medical: Financial Calendar 2026
Announcement no. 57/2025
Reykjavik, Iceland/Copenhagen, Denmark, December 12, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today published its financial calendar for 2026.
Financial Calendar 2026
3 February 2026 Interim Report Q4 2025/2025 Annual Report
10 March 2026 2026 Annual General Meeting
28 April 2026 Interim Report Q1 2026
21 July 2026 Interim Report Q2 2026
20 October 2026 Interim Report Q3 2026
2 February 2027 Interim Report Q4 2026/2026 Annual Report
For further information please contact
Klaus Sindahl
Head of Investor Relations
M: +45 5363 0134
Embla Medical press releases by e-mail
If you wish to receive Embla Medical press releases by e-mail, please register at http://www.emblamedical.com/investors
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) was founded in Reykjavik in 1971 with the mission to improve people's mobility. Embla Medical is home to several brands renowned for positively impacting people's health and well-being. They include Össur, a leading global provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park Industries, creators of custom-built prosthetic solutions. Embla Medical also provides patients with world-class care through a global network of Orthotic and Prosthetic (O&P) facilities. Embla Medical is committed to sustainable business practices and is signatory to the UN Global Compact, UN Women's Empowerment Principles, and contributes to the UN Sustainable Development Goals. The company's climate targets have been verified by the Science Based Targets initiative. Embla Medical operates globally and has more than 4,000 employees. www.emblamedical.com